About 23andMe Holding Co. 
23andMe Holding Co.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 31 Schemes (15.72%)
Foreign Institutions
Held by 65 Foreign Institutions (3.41%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
25 Million
(Quarterly Results - Jun 2025)
Net Profit:
-24 Million
Pharmaceuticals & Biotechnology
USD 113 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
0.31
352.04%
-2.63






